Paolo De Caprariis
University of Salerno
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Paolo De Caprariis.
European Journal of Pharmaceutical Sciences | 2001
Francesco Bonina; Carmelo Puglia; Tony Barbuzzi; Paolo De Caprariis; Francesco Palagiano; Maria Grazia Rimoli; Antonella Saija
Novel polyoxyethylene esters of ketoprofen (1(a-e)), naproxen (2(a-e)) and diclofenac (3(a-e)) were synthesized and evaluated as potential dermal prodrugs of naproxen, ketoprofen and diclofenac. These esters were obtained by coupling these drugs with polyoxyethylene glycols by a succinic acid spacer. The aqueous solubilities, lipophilicities and hydrolysis rates of esters 1(a-e), 2(a-e) and 3(a-e) were determined in a buffered solution and in porcine esterase. The permeation of these prodrugs through excised human skin was studied in vitro. Furthermore we investigated the in vivo topical anti-inflammatory activity of esters 1(d), 2(e) and 3(e), which showed the best in vitro profile, evaluating the ability of these compounds to inhibit methyl nicotinate (MN)-induced skin erythema on healthy human volunteers. Esters 1(a-e), 2(a-e) and 3(a-e) showed good water stability and rapid enzymatic cleavage and their hydrolysis rates, both chemical and enzymatic, were not significantly affected by the length of the polyoxyethylenic chain used as promoiety. Concerning in vitro percutaneous absorption studies, only esters 1(d-e), 2(d-e) and 3(c-e) showed an increased flux through stratum corneum and epidermis membranes compared to their respective parent drugs. In vivo results showed an interesting delayed and sustained activity of esters 1(d) and 3(e) compared to the parent drugs. In conclusion polyoxyethylene glycols could prove to be suitable promoieties for ketoprofen, naproxen and diclofenac design since esters 1(d-e), 2(d-e) and 3(c-e) showed some requirements (chemical stability, enzymatic lability and an increased skin permeation) needed to obtain successful dermal prodrugs. Furthermore, was observed an appreciable and sustained in vivo topical anti-inflammatory activity of esters 1(d) and 3(e), compared to the parent drugs, using MN-induced erythema in human volunteers as inflammation model.
Aaps Pharmscitech | 2006
Carmelo Puglia; Rosanna Filosa; Antonella Peduto; Paolo De Caprariis; Francesco Bonina; Paolo Blasi
In the present study, 2 alternative strategies to optimize ketorolac transdermal delivery, namely, prodrugs (polyoxyethylene glycol ester derivatives, I–IV) and nanostructured lipid carriers (NLC) were investigated. The synthesized prodrugs were chemically stable and easily degraded to the parent drug in human plasma. Ketorolac-loaded NLC with high drug content could be successfully prepared. The obtained products formulated into gels showed a different trend of drug permeation through human stratum corneum and epidermis. Particularly, skin permeation of ester prodrugs was significantly enhanced, apart from ester IV, compared with ketorolac, while the results of drug release from NLC outlined that these carriers were ineffective in increasing ketorolac percutaneous absorption owing to a higher degree of mutual interaction between the drug and carrier lipid matrix. Polyoxyethylene glycol esterification confirmed to be a suitable approach to enhance ketorolac transdermal delivery, while NLC seemed more appropriate for sustained release owing to the possible formation of a drug reservoir into the skin.
Journal of Drug Targeting | 2003
Francesco Bonina; Carmelo Puglia; Maria Grazia Rimoli; Daniela Melisi; Giampiero Boatto; Maria Nieddu; Antonio Calignano; Giovanna La Rana; Paolo De Caprariis
Novel glycosyl derivatives of dopamine and l-dopa (I–IV) are synthesized in order to overcome the problem of blood–brain barrier low permeability of dopamine and of low bioavailability of its precursor l-dopa. Esters synthesized link dopamine and l-dopa, by a succinyl linker, to C-3 position of glucose (I and III) and to C-6 of galactose (II and IV). The chemical and enzymatic stabilities of esters synthesized were evaluated in order to determine both their stability in aqueous medium and their feasibility in undergoing enzymatic cleavage by rat plasma to regenerate the original drug. Furthermore, we have shown the central effects of esters I–IV on classic dopaminergic models, such as morphine induced locomotion and reserpine-induced hypolocomotion. From the result obtained compounds I–IV appeared moderately stable in a pH 7.4 buffered solution and in rat plasma. Furthermore, pharmacological studies showed that both dopamine derivatives (I and II) were equiactive in reversing reserpine-induced hypolocomotion in rats, and both were more active than l-dopa or ester III and IV, while II and III were more potent in reducing morphine-induced locomotion than I and IV. The minimal vascular effects of these derivatives allow us to underline the possibility to use them in pathologies, such as Parkinson disease, characterised by an evident decreasing of dopamine concentration in the brain.
International Journal of Pharmaceutics | 2000
Francesco Bonina; Loredana Arenare; Rosa Ippolito; Gianpiero Boatto; Giuseppe Battaglia; Valeria Bruno; Paolo De Caprariis
7-Chlorokynurenic acid 1 is a potent glycine-N-methyl-D-aspartate (NMDA) receptor antagonist, but it shows weak activity after systemic administration. In order to overcome the Blood-brain barrier (BBB), we synthetized three new esters 2-4 of 1 obtained by chemical conjugation with essential nutrients such as glucose and galactose, that are actively transported across the BBB. These compounds were assayed to evaluate their in vitro chemical and enzymatic hydrolysis. In addition the prodrugs 2-4 were tested for their ability to protect mice against NMDA-induced seizures after systemic administration. All the prodrugs 2-4 appeared moderately stable in pH 7.4 buffered solution and were susceptible to in vitro enzymatic hydrolysis. Intraperitoneal administration of either esters 2 or 4 was highly protective against seizures induced by NMDA in mice, with the latter prodrug showing the highest anticonvulsive activity. In addition, ester 4 undergoes a time-dependent extracellular hydrolysis into 1 when applied to mixed cultures of mouse cortical cells, a model that reproduces in vitro the cellular milieu encountered by the prodrugs once they penetrate the brain parenchyma.
Beilstein Journal of Organic Chemistry | 2015
Antonia Di Mola; Maximilian Tiffner; Francesco Scorzelli; Laura Palombi; Rosanna Filosa; Paolo De Caprariis; Mario Waser; Antonio Massa
Summary New bifunctional chiral ammonium salts were investigated in an asymmetric cascade synthesis of a key building block for a variety of biologically relevant isoindolinones. With this chiral compound in hand, the development of further transformations allowed for the synthesis of diverse derivatives of high pharmaceutical value, such as the Belliotti (S)-PD172938 and arylated analogues with hypnotic sedative activity, obtained in good overall total yield (50%) and high enantiomeric purity (95% ee). The synthetic routes developed herein are particularly convenient in comparison with the current methods available in literature and are particularly promising for large scale applications.
European Journal of Medicinal Chemistry | 2011
Carmen Petronzi; Rosanna Filosa; Antonella Peduto; Maria Chiara Monti; Luigi Margarucci; Antonio Massa; Simona Francesca Ercolino; Valentina Bizzarro; Luca Parente; Raffaele Riccio; Paolo De Caprariis
As a part of our drug discovery efforts we developed a series of simplified derivatives of bolinaquinone (BLQ), a hydroxyquinone marine metabolite, showing potent anti-inflammatory activity. Thirteen new hydroxyquinone derivatives closely related to BLQ were synthesized and tested on mouse macrophage-like RAW 264.7 cell line in order to investigate their ability to modulate the production of Prostaglandin E2 (PGE2). This optimization process led to the identification of three strictly correlated compounds with comparable and higher inhibitory potency than BLQ on PGE2 production. To evaluate the affinity of BLQ and its analogues for hsPLA2, surface plasmon resonance (SPR) experiments were performed.
Bioorganic & Medicinal Chemistry | 2010
Grazia Sellitto; Aurora Faruolo; Paolo De Caprariis; Sergio Altamura; Giacomo Paonessa; Gennaro Ciliberto
A series of ethyl 1H-indole-3-carboxylates 9a(1)(-)(6) and 9b(1)(-)(2) were prepared and evaluated in Huh-7.5 cells. Most of the compounds exhibited anti-hepatitis C virus (HCV) activities at low concentration. The selectivity indices of inhibition on entry and replication of compounds 9a(2) (>10; >16.7) and 9b(1) (>6.25; >16.7) were higher than those of the other evaluated compounds, including the lead compound Arbidol (ARB, 6; 15). Moreover, the selective index of inhibition on entry of compound 9a(3) (>6.25) was higher than that of ARB (6). Of these three initial hits, compound 9a(2) was the most potent.
Journal of Natural Products | 2008
Giuseppina Cioffi; Fabrizio Dal Piaz; Antonio Vassallo; Fabio Venturella; Paolo De Caprariis; Francesco De Simone; Nunziatina De Tommasi
Eight new oleanane saponins (1- 8) together with four know saponins (9-12) were isolated from the aerial parts of Meryta denhamii. Their structures were elucidated by 1D and 2D NMR experiments including 1D TOCSY, DQF-COSY, ROESY, HSQC, and HMBC spectroscopy, as well as ESIMS analysis. The antiproliferative activity of all compounds was evaluated using three murine and human cancer cell lines: J774.A1, HEK-293, and WEHI-164.
Journal of Controlled Release | 1996
Francesco Bonina; Lucia Montenegro; Paolo De Caprariis; Francesco Palagiano; Anna Capasso; L. Sorrentino
Abstract The pharmacokinetic and pharmacodynamic profile of triethylene glycol indomethacin ester (TIE), an indomethacin oral prodrug, was investigated after oral administration to rats (indomethacin 5 mg/kg; TIE 20 mg/kg). In vitro enzymatic hydrolysis studies using rat plasma showed that TIE was quantitatively reconverted into indomethacin at a very fast rate. After TIE oral dosing, indomethacin mean peak plasma concentration was lower than after indomethacin administration (16.30 and 30.25 μg/ml, respectively) and mean time to the peak plasma concentration was slightly higher than that observed after indomethacin (4 and 3 h, respectively). TIE oral administration to rats gave lower but relatively constant indomethacin plasma levels for the observation period (24 h). The results from the biological response time course of carrageenan-induced paw edema after indomethacin and TIE administration showed that both drug and prodrug were able to inhibit the inflammatory process over the observation period (7 h). Furthermore, the paw/blood concentration ratio of indomethacin 3 h after carrageenan injection was similar after oral administration of indomethacin or TIE. TIE pharmacokinetic profile could be attributed to a different absorption of the prodrug in the gastrointestinal tract compared to indomethacin.
Journal of Medical Microbiology | 2014
Brunella Perfetto; Rosanna Filosa; Vincenza De Gregorio; Antonella Peduto; Annalisa La Gatta; Paolo De Caprariis; Maria Antonietta Tufano; Giovanna Donnarumma
Arbidol (ARB) is an antiviral drug that has broad-spectrum activity against a number of viral infections. To date, there are no specific data regarding its effects against a herpesvirus. Here, the in vitro antiviral effect of ARB and structurally related derivatives were evaluated in HaCat cells on different steps of herpes simplex virus type 1 replication: adsorption, entry and post-entry. The simplified pyrrolidine analogue, 9a2, showed the best antiviral activity in vitro by reducing the plaque numbers by about 50% instead of 42% obtained with ARB at the same concentration. Furthermore, we have reported that all tested compounds evaluated for their immunomodulatory activity showed the ability to reduce the viral proteins VP16 and ICP27 and to modify the virus-induced cytokine expression, allowing the host cell a more efficient antiviral response.